vs
Side-by-side financial comparison of Brightstar Lottery PLC (BRSL) and Quest Diagnostics (DGX). Click either name above to swap in a different company.
Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $2.5B, roughly 1.2× Brightstar Lottery PLC). Quest Diagnostics runs the higher net margin — 9.7% vs 5.9%, a 3.9% gap on every dollar of revenue.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
BRSL vs DGX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.9B |
| Net Profit | $147.0M | $281.0M |
| Gross Margin | — | — |
| Operating Margin | 11.9% | 15.4% |
| Net Margin | 5.9% | 9.7% |
| Revenue YoY | — | 9.2% |
| Net Profit YoY | — | 12.0% |
| EPS (diluted) | $0.74 | $2.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.9B | ||
| Q4 25 | $2.5B | $2.8B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $281.0M | ||
| Q4 25 | $147.0M | $245.0M | ||
| Q3 25 | — | $245.0M | ||
| Q2 25 | — | $282.0M | ||
| Q1 25 | — | $220.0M | ||
| Q4 24 | — | $222.0M | ||
| Q3 24 | — | $226.0M | ||
| Q2 24 | — | $229.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.4% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 34.2% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 33.5% |
| Q1 26 | — | 15.4% | ||
| Q4 25 | 11.9% | 13.8% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | — | 13.8% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 14.8% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | 5.9% | 8.7% | ||
| Q3 25 | — | 8.7% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 9.1% | ||
| Q2 24 | — | 9.6% |
| Q1 26 | — | $2.24 | ||
| Q4 25 | $0.74 | $2.18 | ||
| Q3 25 | — | $2.16 | ||
| Q2 25 | — | $2.47 | ||
| Q1 25 | — | $1.94 | ||
| Q4 24 | — | $1.95 | ||
| Q3 24 | — | $1.99 | ||
| Q2 24 | — | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $393.0M |
| Total DebtLower is stronger | $4.1B | $5.7B |
| Stockholders' EquityBook value | $875.0M | $7.7B |
| Total Assets | $9.2B | $16.7B |
| Debt / EquityLower = less leverage | 4.64× | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $393.0M | ||
| Q4 25 | $1.4B | $420.0M | ||
| Q3 25 | — | $432.0M | ||
| Q2 25 | — | $319.0M | ||
| Q1 25 | — | $188.0M | ||
| Q4 24 | — | $549.0M | ||
| Q3 24 | — | $764.0M | ||
| Q2 24 | — | $271.0M |
| Q1 26 | — | $5.7B | ||
| Q4 25 | $4.1B | $5.2B | ||
| Q3 25 | — | $5.2B | ||
| Q2 25 | — | $5.2B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | — | $5.6B | ||
| Q3 24 | — | $5.6B | ||
| Q2 24 | — | $3.8B |
| Q1 26 | — | $7.7B | ||
| Q4 25 | $875.0M | $7.2B | ||
| Q3 25 | — | $7.3B | ||
| Q2 25 | — | $7.2B | ||
| Q1 25 | — | $6.9B | ||
| Q4 24 | — | $6.8B | ||
| Q3 24 | — | $6.8B | ||
| Q2 24 | — | $6.6B |
| Q1 26 | — | $16.7B | ||
| Q4 25 | $9.2B | $16.2B | ||
| Q3 25 | — | $16.2B | ||
| Q2 25 | — | $16.0B | ||
| Q1 25 | — | $15.8B | ||
| Q4 24 | — | $16.2B | ||
| Q3 24 | — | $16.1B | ||
| Q2 24 | — | $13.9B |
| Q1 26 | — | 0.74× | ||
| Q4 25 | 4.64× | 0.72× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.85× | ||
| Q4 24 | — | 0.83× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | 0.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-99.0M | $278.0M |
| Free Cash FlowOCF − Capex | $-415.0M | — |
| FCF MarginFCF / Revenue | -16.5% | — |
| Capex IntensityCapex / Revenue | 12.6% | 3.9% |
| Cash ConversionOCF / Net Profit | -0.67× | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $278.0M | ||
| Q4 25 | $-99.0M | $465.0M | ||
| Q3 25 | — | $563.0M | ||
| Q2 25 | — | $544.0M | ||
| Q1 25 | — | $314.0M | ||
| Q4 24 | — | $464.0M | ||
| Q3 24 | — | $356.0M | ||
| Q2 24 | — | $360.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-415.0M | $307.0M | ||
| Q3 25 | — | $419.0M | ||
| Q2 25 | — | $436.0M | ||
| Q1 25 | — | $197.0M | ||
| Q4 24 | — | $341.0M | ||
| Q3 24 | — | $250.0M | ||
| Q2 24 | — | $268.0M |
| Q1 26 | — | — | ||
| Q4 25 | -16.5% | 10.9% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 15.8% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 11.2% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 12.6% | 5.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | — | 3.8% |
| Q1 26 | — | 0.99× | ||
| Q4 25 | -0.67× | 1.90× | ||
| Q3 25 | — | 2.30× | ||
| Q2 25 | — | 1.93× | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | 2.09× | ||
| Q3 24 | — | 1.58× | ||
| Q2 24 | — | 1.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
